IEA's "Smokefree 2030 Plan" Encourages Low-Risk Alternatives to Cigarettes

Nov.03.2022
IEA's "Smokefree 2030 Plan" Encourages Low-Risk Alternatives to Cigarettes
A new report from IEA suggests using e-cigarettes and other safer alternatives to reduce smoking rates in the UK.

Prior to the parliamentary debate on the independent review of the Smoke-Free 2030 policy on November 3rd, the Institute of Economic Affairs (IEA) released an alternative strategy aimed at reducing smoking rates in the UK, called the "Smoke-Free 2030 Plan B.


This approach is in stark contrast to the recent Khan review, which suggested gradually phasing out the sale of cigarettes over time. The report's author, Christopher Snowdon, believes that as long as there is demand - with only 53% of UK smokers stating they want to quit - a ban on smoking will lead to black market activity, crime, and poverty without eradicating smoking.


Christopher Snowdon, as reported by tobaccoreporter.


A new plan to aid smoking cessation has been proposed, highlighting the success of electronic cigarettes and other safer alternatives. According to data from the IEA, in the UK, 9.3% of adults now use e-cigarettes, causing smoking rates to drop from 20% in 2012 to 14%. In the EU, where only 2% of adults use e-cigarettes, smoking rates declined by only 1% from 2014 to 2020. As of this year, 28% of smokers have never attempted to use e-cigarettes, so removing barriers to access low-risk nicotine alternatives is crucial.


The Head of Lifestyle Economics at the IEA, Christopher Snowdon, has advised the government to address widespread misinformation about the risks of e-cigarettes. Currently, 40% of smokers in the UK incorrectly believe that nicotine causes cancer. Furthermore, between 2014 and 2020, the proportion of smokers who incorrectly perceived e-cigarettes to be as dangerous or more dangerous than smoking increased from 36% to 53%. The conclusions drawn by the Royal College of Physicians suggest that the long-term risks of e-cigarette use are "unlikely to exceed 5% of those associated with smoking". The government should ensure that public health agencies promote the benefits of e-cigarettes relative to smoking.


Edward Snowden also suggested that the government should accept the freedom offered by Brexit to reform the Tobacco Products Directive (TPD). Article 20 of the TPD contains punitive regulations for e-cigarettes, covering everything from advertising to the size of refillable vape tanks. According to Snowden, reducing these burdensome regulations will remove significant barriers to entry.


Smokers can be encouraged to quit by reducing the burdensome regulations on alternative low-risk tobacco products such as heated tobacco and nicotine pouches. These products are subject to overly strict regulations, with snuff being banned in the UK.


According to the IEA, the UK has generally exercised wise regulation of e-cigarettes. However, the think tank believes that with more emphasis on promoting the switch to low-risk tobacco alternatives and relaxing relevant regulatory frameworks, smoking may truly become a thing of the past.


The government's plan to reduce smoking rates to 5% by 2030 is highly unlikely to be achieved without a significant shift towards low-risk alternatives, according to Snowden. Fortunately, there are more and more alternatives available. The government needs to create a regulatory environment that allows these alternatives to thrive and ensures that smokers are not misled by fake news. There are a number of simple, low-cost reforms that could help the government reach its health goals without persecuting smokers.


Statement:


This article is compiled from third-party information and is intended solely for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truth or accuracy of the article's content. The translation of this article is only intended for industry communication and research purposes.


Due to limitations in translation proficiency, the translated article may not fully express the same meaning as the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on all domestic, Hong Kong/Macau/Taiwan-related, and foreign-related statements and positions.


The compilation of information is the property of the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
At the 2026 NACS Show, Altria displayed Ploom devices alongside imagery of Marlboro-branded heated tobacco sticks, while also featuring RIOT Energy and Proper Wild non-nicotine products. The booth showcased on! PLUS nicotine pouches, including 12 mg variants not listed among FDA-authorized products as of October 9, and NJOY e-cigarettes. Altria also presented convenience-store traffic figures highlighting its retail presence. 2Firsts examines the company's expanded product portfolio, non-nicotine business activities and the regulatory status of products displayed at the show.
EXPO
Oct.10
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
Italian Financial Police Seize 4.3 Million E-Cigarettes and Smoking Accessories; 28 Reported to Judicial Authorities Across Operations
Italian Financial Police Seize 4.3 Million E-Cigarettes and Smoking Accessories; 28 Reported to Judicial Authorities Across Operations
Italy's Guardia di Finanza announced on October 28 that officers in Latina province had seized approximately 4.3 million e-cigarettes and smoking accessories at an unauthorized warehouse in an operation involving restrictions on the possession and sale of tobacco-related products. Another 300,000 suspected counterfeit or unsafe items were confiscated during separate inspections, bringing total seizures across the operations to more than 4.6 million products. Twenty-eight people were reported to judicial authorities over suspected smuggling and counterfeiting offenses. Officials did not disclose separate vape quantities, the value of the merchandise or alleged violations associated with individual brands.
Enforcement
Oct.29